1) salmeterol/fluticasone propionate (seretide)
沙美特罗替卡松(舒利迭)
1.
Objective To explore the effects of combining salmeterol/fluticasone propionate (seretide) and montelukast sodium (singulair) on patients with COPD by analyzing lung function.
目的探讨沙美特罗替卡松(舒利迭)联合孟鲁斯特钠(顺尔宁)对慢性阻塞性肺疾病(COPD)患者肺功能的影响。
2) salmeterol/flutieasone propionate
沙美特罗/氟替卡松(舒利迭)
3) Salmeterol/fluticasone propionate
沙美特罗替卡松
1.
Lung function and safety of children with moderate-severe asthma treated by salmeterol/fluticasone propionate;
沙美特罗替卡松治疗儿童中重度哮喘的肺功能及安全性观察
4) Salmeterol/Fluticasone
沙美特罗替卡松
1.
The Improvement of Salmeterol/Fluticasone on Inspiratory Capacity in Patients with Stable Chronic Obstructive Pulmonary Disease;
沙美特罗替卡松对稳定期COPD患者深吸气量的改善作用
2.
Salmeterol/Fluticasone Powder Inhalation for Patients with Cough-Variant Asthma: Clinical Observation on 43 Cases;
沙美特罗替卡松粉吸入剂治疗咳嗽变异型哮喘43例临床观察
补充资料：沙美特罗
分子式：C25H37NO3
分子量：暂无
CAS号：89365-50-4
性质：暂无
制备方法：暂无
用途：支气管扩张药。
分子量：暂无
CAS号：89365-50-4
性质：暂无
制备方法：暂无
用途：支气管扩张药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条